A Phase I/II Trial of UCB4594 in Participants With Advanced Cancer

Conditions

• Advanced Solid Tumours
• Squamous Cell Carcinoma of Head and Neck
• Carcinoma, Non-Small-Cell Lung
• Colorectal Neoplasms
• Triple Negative Breast Neoplasms
• Carcinoma, Renal Cell (Clear Cell Only)
• Esophageal Neoplasms
• Stomach Neoplasms (Excluding Gastrointestinal Stromal Tumors)
• Uterine Cervical Neoplasms
• Ovarian Neoplasms
• Pancreatic Neoplasms

Interventions

• DRUG: UCB4594

Sponsor

Cancer Research UK

Collaborators

• [object Object]